HOME >> BIOLOGY >> NEWS
An infectious agent of deception, exposed through proteomics

RICHLAND, Wash. -- Salmonella bacteria, infamous for food poisoning that kills hundreds of thousands worldwide, infect by stealth. They slip unnoticed into and multiply inside macrophages, the very immune system cells the body relies on to seek and destroy invading microbes.

Just how Salmonella escapes detection by macrophages, turning predator cells to prey complicit in promoting infection, has seemed impossibly complicated, a needle-in-a-haystack proposition involving thousands of proteins, the building blocks that carry out cells' vital functions.

Applying the high-volume sorting and analytical power of proteomics--a detailed survey of microbial proteins present in the 24 hours that follow mouse-macrophage infection--a team led by Liang Shi of the Department of Energy's Pacific Northwest National Laboratory has turned up a suspect protein.

The discovery of the protein, dubbed STM3117, is detailed today (Sept. 29) in The Journal of Biological Chemistry. Knocking out the gene that codes for STM3117, the researchers subsequently crippled the microbe's ability to multiply inside macrophages. Shi and colleagues say the protein and two closely related proteins discovered in the study are similar in genetic sequence to those known to make and modify chemicals in the microbe's cell wall called peptidoglycan.

Drug and vaccine designers armed with this mouse-model information can target chemicals or immune responses that disrupt peptidoglycan synthesis and other processes linked to Salmonella's colonization of macrophages in humans, said Joshua Adkins, a co-author on Shi's paper and lead author of a related study in Molecular & Cellular Proteomics last month. A quick identification of these proteins, Adkins added, could help physicians assess the virulence of a given strain.

The candidate proteins were winnowed from among 315 possibilities that emerged through a combination of techniques, culminating in measurements by
'"/>

Contact: Bill Cannon
cannon@pnl.gov
509-375-3732
DOE/Pacific Northwest National Laboratory
29-Sep-2006


Page: 1 2

Related biology news :

1. First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
2. Scientists concerned about effects of global warming on infectious diseases
3. Scientists identify prions infectious secret
4. Bacteria control how infectious they become, study finds
5. Discovery of chemical profiles for infectious diarrhea
6. Ikerlan-IK4 and Gaiker-IK4 patent device for rapid diagnosis of infectious diseases and cancer
7. Identification of carbon dioxide receptors in insects may help fight infectious disease
8. Leading scientists gather to discuss developments in infectious disease research
9. Human behavior changes the number of strains of infectious diseases
10. Brittle prions are more infectious
11. Researchers map infectious hepatitis B virus

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: infectious agent deception exposed through proteomics

(Date:5/17/2013)... of all ages will celebrate the science and ... our daily lives during the inaugural Atlanta Science ... educators from local museums, corporations, K-12 schools and ... different events for children and adults at venues ... . , The annual Atlanta Science Festival ...
(Date:5/17/2013)... (Intelligent Cargo in Efficient and Sustainable Global Logistics Operations) ... improvement in the efficiency of intermodal loading systems and ... It comprises 29 European organisations with experience in the ... a budget totalling 17,000,000 and a duration of three ... specify and develop the semantic components and ontologies shared ...
(Date:5/17/2013)... An international team of scientists using a new ... inside a living frog embryo in greater detail than ... advance biological research and the search for new treatments ... Karlsruher Institut fr Technologie in Germany, in collaboration with ... Energy,s Argonne National Laboratory, released the most precise depiction ...
Breaking Biology News(10 mins):First Atlanta Science Festival set for 2014 2New logistics services that will cut energy consumption and CO2 emissions 2New X-ray method shows how frog embryos could help thwart disease 2
(Date:5/20/2013)... Ras Al Khaimah, UAE (PRWEB) May 21, 2013 ... and private equity consultancy specializing in “game-changing” life science ... appointment of Ms. Dalia Dergham to its International Project ... certain to bring even greater multi-cultural depth to Grace ... more projects around the globe. , Ms. Dergham holds ...
(Date:5/20/2013)... , May 20, 2013 Today, at the ... Francisco , James McGough , ... at the Semel Institute for Neuroscience and Human Behavior ... Medicine at the University of California Los Angeles (UCLA), ... and Adolescent Psychopharmacology and ADHD at UCLA, presented the ...
(Date:5/20/2013)... SEATTLE , May 20, 2013 Pacific Biomarkers ... laboratory solutions for developers of biosimilars at the ... the Sheraton San Diego Hotel and Marina ... Attendees will have the opportunity to speak with company ... Development: Paths That Cross" on May 21 from 1-2 ...
(Date:5/20/2013)... HILL, N.C. , May 20, 2013 /PRNewswire/ ... company focused on developing differentiated antibiotics to meet ... infections, today announced that it presented data at ... in Philadelphia demonstrating the ... levofloxacin in Cempra,s prior Phase 2 clinical trial ...
Breaking Biology Technology:Dalia Dergham Joins Grace Century FZ LLC International Project Team 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2
Cached News: